According to the provisions of the Equity Transfer Agreement of Chengde Tianyuan Pharmaceutical Co., Ltd., as of the date of the announcement, Beilu Pharmaceutical has completed the transfer of management rights and other work and has fully paid the entire transfer price of this transaction to Goldenmax International Group Co., Ltd. The matter of the company's acquisition of 80% equity of Chengde Tianyuan Pharmaceutical Co., Ltd. has been completed.
北陆药业：完成收购承德天原药业80%股权
Beijing Beilu Pharmaceutical: Completes acquisition of 80% equity of Chengde Tianyuan Pharmaceutical.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.